Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease
J Transl Med. 2024 Jun 13;22(1):566.
doi: 10.1186/s12967-024-05348-8.
11 Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
12 Klinik Für Stammzelltransplantation, Universitätsklinikum, Hamburg, Germany.
13 Hämatologie Und Medizinische Onkologie, Universitätsmedizin Göttingen, Göttingen, Germany.
14 Universitätsklinikum Köln, Cologne, Germany.
15 Institute for Clinical Transfusion Medicine and Immunogenetics, University of Ulm, Ulm, Germany.
16 Department of Pediatrics, Division for Stem Cell Transplantation and Immunology, Goethe University, Frankfurt, Germany.
17 Medac Gesellschaft Für Klinische Spezialpräparate mbH, Wedel, Germany.
18 Department Innere Medizin, Klinik Für Innere Medizin I, Universitätsklinikum Freiburg, Freiburg, Germany.
19 Department of Pediatrics, Division of Stem Cell Transplantation and Immunology, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
20 Department of Pediatrics, Division of Stem Cell Transplantation and Immunology, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. [email protected].